These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 27029061)

  • 1. Lysine demethylase 2A promotes stemness and angiogenesis of breast cancer by upregulating Jagged1.
    Chen JY; Li CF; Chu PY; Lai YS; Chen CH; Jiang SS; Hou MF; Hung WC
    Oncotarget; 2016 May; 7(19):27689-710. PubMed ID: 27029061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian lysine histone demethylase KDM2A regulates E2F1-mediated gene transcription in breast cancer cells.
    Rizwani W; Schaal C; Kunigal S; Coppola D; Chellappan S
    PLoS One; 2014; 9(7):e100888. PubMed ID: 25029110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysine demethylase 2A expression in cancer-associated fibroblasts promotes breast tumour growth.
    Chen JY; Li CF; Lai YS; Hung WC
    Br J Cancer; 2021 Jan; 124(2):484-493. PubMed ID: 33024266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of histone demethylase KDM2A enhanced the adipogenic and chondrogenic differentiation potentials of stem cells from apical papilla.
    Dong R; Yao R; Du J; Wang S; Fan Z
    Exp Cell Res; 2013 Nov; 319(18):2874-82. PubMed ID: 23872478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells.
    Dhar SS; Alam H; Li N; Wagner KW; Chung J; Ahn YW; Lee MG
    J Biol Chem; 2014 Mar; 289(11):7483-96. PubMed ID: 24482232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.
    Liu H; Liu L; Holowatyj A; Jiang Y; Yang ZQ
    Mol Carcinog; 2016 May; 55(5):977-90. PubMed ID: 26207617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone demethylase KDM4C regulates sphere formation by mediating the cross talk between Wnt and Notch pathways in colonic cancer cells.
    Yamamoto S; Tateishi K; Kudo Y; Yamamoto K; Isagawa T; Nagae G; Nakatsuka T; Asaoka Y; Ijichi H; Hirata Y; Otsuka M; Ikenoue T; Aburatani H; Omata M; Koike K
    Carcinogenesis; 2013 Oct; 34(10):2380-8. PubMed ID: 23698634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV16 E7-induced upregulation of KDM2A promotes cervical cancer progression by regulating miR-132-radixin pathway.
    Ou R; Zhu L; Zhao L; Li W; Tao F; Lu Y; He Q; Li J; Ren Y; Xu Y
    J Cell Physiol; 2019 Mar; 234(3):2659-2671. PubMed ID: 30132864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
    Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
    EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of histone demethylase KDM2A inhibited cell proliferation of stem cells from apical papilla by de-repression of p15INK4B and p27Kip1.
    Gao R; Dong R; Du J; Ma P; Wang S; Fan Z
    Mol Cell Biochem; 2013 Jul; 379(1-2):115-22. PubMed ID: 23559091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXA-AS2 contributes to regulatory T cell proliferation and immune tolerance in glioma through the miR-302a/KDM2A/JAG1 axis.
    Zhong C; Tao B; Li X; Xiang W; Peng L; Peng T; Chen L; Xia X; You J; Yang X
    Cell Death Dis; 2022 Feb; 13(2):160. PubMed ID: 35181676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling.
    Wagner KW; Alam H; Dhar SS; Giri U; Li N; Wei Y; Giri D; Cascone T; Kim JH; Ye Y; Multani AS; Chan CH; Erez B; Saigal B; Chung J; Lin HK; Wu X; Hung MC; Heymach JV; Lee MG
    J Clin Invest; 2013 Dec; 123(12):5231-46. PubMed ID: 24200691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone demethylase KDM2A suppresses EGF-TSPAN8 pathway to inhibit breast cancer cell migration and invasion in vitro.
    Zhang H; Tu Y; Huang B; Xiao J; Xiao J; Wang J; Pei Y; Yang R; Feng J; Li J; Zhang X
    Biochem Biophys Res Commun; 2022 Nov; 628():104-109. PubMed ID: 36084547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of miR-663a inhibits the cancer stem cell-like properties of glioma via repressing the KDM2A-mediated TGF-β/SMAD signaling pathway.
    Wang L; Lang B; Zhou Y; Ma J; Hu K
    Cell Cycle; 2021 Oct; 20(19):1935-1952. PubMed ID: 34424812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
    Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
    J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
    Ramadoss S; Guo G; Wang CY
    Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas.
    De Nicola I; Guerrieri AN; Penzo M; Ceccarelli C; De Leo A; Trerè D; Montanaro L
    Histol Histopathol; 2020 Oct; 35(10):1181-1187. PubMed ID: 32901907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA1-regulated JAG1 promotes ovarian cancer progression by activating Notch signal pathway.
    Liu Z; Zhu Y; Li F; Xie Y
    Protoplasma; 2020 May; 257(3):901-910. PubMed ID: 31897811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine demethylase KDM2A inhibits TET2 to promote DNA methylation and silencing of tumor suppressor genes in breast cancer.
    Chen JY; Luo CW; Lai YS; Wu CC; Hung WC
    Oncogenesis; 2017 Aug; 6(8):e369. PubMed ID: 28785073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.